Towards the synthesis and delivery of a halogenated MCT1 substrate
<p>The monocarboxylate transporter 1 (MCT1) has received special attention as a potential therapeutic target in cancer thanks to its role in lactate shuttling. In breast cancer (BC), high MCT1 expression has been correlated with basal-like phenotype and a ‘triple-negative’ status, an aggressiv...
Main Author: | Skaripa-Koukelli, Eirini |
---|---|
Other Authors: | Vallis, K |
Format: | Thesis |
Language: | English |
Published: |
2019
|
Subjects: |
Similar Items
-
Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review
by: Paul M. D. Gape, et al.
Published: (2024-03-01) -
Imaging and therapy with radionuclide labeled magnetic nanoparticles
by: Perihan Ünak
Published: (2008-12-01) -
Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles
by: Iturrioz-Rodríguez N, et al.
Published: (2019-05-01) -
RNA nanostructures for targeted drug delivery and imaging
by: Laura Teodori, et al.
Published: (2024-12-01) -
RGD Forever!—Past, Present, and Future of a 3-Letter-Code in Radiopharmacy and Life Sciences
by: Johannes Notni
Published: (2022-12-01)